Related Experiment Video
Updated: Aug 19, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Coronary artery disease and coronary artery bypass grafting in Behçet's disease
Mesut Sismanoglu1, Suat Nail Omeroglu, Denyan Mansuroglu
1Kosuyolu Heart and Research Hospital, Istanbul, Turkey. msismanoglu@kosuyolu.gov.tr
Insights
Behçet's disease patients with coronary artery disease (CAD) face high pseudoaneurysm risks after coronary artery bypass grafting (CABG). A conservative approach is advised due to fragile tissues, with on-pump surgery recommended if CABG is necessary.
Area of Science:
- Cardiovascular Surgery
- Rheumatology
- Vascular Surgery
Background:
- Behçet's disease is associated with a high incidence of pseudoaneurysm formation.
- Inflamed and fragile tissues in Behçet's disease patients pose surgical challenges.
- Coronary artery disease (CAD) is rare in Behçet's disease, typically affecting young males.
Purpose of the Study:
- To report the long-term outcomes of coronary artery bypass grafting (CABG) in patients with Behçet's disease.
- To evaluate the safety and efficacy of surgical versus medical management for CAD in this patient population.
- To highlight the risks of pseudoaneurysm formation in Behçet's disease patients undergoing cardiovascular procedures.
Main Methods:
- Retrospective case series of five patients with Behçet's disease and CAD.
- Three patients underwent coronary artery bypass grafting (CABG).
- Two patients were managed medically.
Main Results:
- No early mortality or morbidity in the studied cohort.
- One patient developed pseudoaneurysm of the ascending aorta and femoral artery, leading to late death.
- Operated patients achieved Canadian Cardiovascular Society (CCS) Class I, while medically treated patients were in CCS Class II at follow-up (mean 41 months).
Conclusions:
- A conservative management strategy is recommended for Behçet's disease patients with CAD due to high post-operative pseudoaneurysm risk.
- If CABG is unavoidable, performing the procedure off-pump with minimal aortic manipulation is advised.
- Long-term results of CABG in Behçet's disease patients are scarce, underscoring the need for cautious management.
Abstract:
There is a high frequency of pseudoaneurysm formation in patients with Behçet's disease and their inflammed and fragile tissues are difficult to manipulate. Five patients with Behçet's disease were referred to our cardiovascular surgery department for coronary artery bypass grafting (CABG). Three of them were operated and two were treated medically. Patients that were managed medically had left anterior descending (LAD) lesions below 80% and their stable angina pectoris responded well to medication. There was no early mortality and morbidity. One patient developed pseudoaneurysm of ascending aorta and femoral artery. This patient died in the late postoperative period. At follow-up the operated patients were in Canadian Cardiovascular Society (CCS) Class I, while the medically treated patients were in CCS Class II. Mean follow-up period was 41 +/- 36.21 months. Coronary artery disease (CAD) is extremely rare detected in patients with Behçet's disease. The affected patients are usually young males. Coronary artery bypass grafting is also rarely performed in these patients and long-term results of such operations are not available in the literature. We present five patients with Behçet's disease that had CAD, three operated and two medically treated, and report their long-term results. We suggest a conservative approach in patients with Behçet's disease because of the high risk of pseudoaneurysm formation in the postoperative period. If CABG cannot be avoided we recommend operating the patients on the beating heart with minimal aortic manipulation.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
